PRX Pharma Produtos Farmacêuticos

PRX Pharma is a Brazilian specialty pharmaceutical company focused on the commercialization and distribution of high-complexity medications for life-threatening and rare diseases. As a member of the Pint Pharma group, the company serves as a strategic partner for international biotechnology firms looking to navigate the regulatory and commercial landscape in Brazil. Their therapeutic portfolio primarily targets oncology, hematology, and rare genetic disorders, featuring innovative treatments such as lurbinectedin and defibrotide. PRX Pharma manages comprehensive market access strategies, including regulatory registration with ANVISA, pricing negotiations, and specialized logistics. The company is dedicated to improving patient outcomes by bridging the gap between global medical innovation and the Brazilian healthcare system.